Interestingly, under the condition of injecting the ChABC, the enhancement of c-Fos expression was absent after stroke or EA treatment (p < 0.01, respectively, Stroke + P-nase: 950.5 ± 91.36, Stroke + ChABC: 502.9 ± 38.36, Stroke + EA + P-nase: 1382 ± 90.87, Stroke + EA + ChABC: 643.6 ± 107.8, cells/mm2; Fig. 3A–C). The gene discussed is FOS; the disease is Stroke.